Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision tag updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:19:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:32:53.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added site revision tag: v3.4.2. The government funding lapse notice was removed, and no study-specific content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:39:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and directs users to opm.gov for status updates, and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:24:40.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle. Footer text was updated to show 'Last Update Submitted that Met QC Criteria' with capitalization changes, and it adds 'No FEAR Act Data' and 'Revision: v3.4.0' while the previous 'No FEAR Act data' wording is removed.
    Difference
    0.2%
    Check dated 2026-01-28T04:25:41.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Minor page revision: Revision v3.3.4 was added and v3.3.3 removed. No changes to study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:17.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.